Sign in

You're signed outSign in or to get full access.

Susan Kilsby

Non-Executive Chair of the Board at Fortune Brands Innovations
Board

About Susan S. Kilsby

Susan S. Kilsby (age 66) is Fortune Brands Innovations’ independent Non‑Executive Chair and Class II director nominee, serving on the Board since 2015. A former senior investment banker with deep M&A expertise, she chairs the Nominating, Environmental, Social & Governance (NESG) Committee and the Executive Committee, and leads independent director executive sessions, reflecting strong governance oversight and Board effectiveness. Current external roles include Senior Independent Director at Diageo plc and non‑executive director at Unilever plc; she is also a member of the UK Takeover Panel.

Past Roles

OrganizationRoleTenureCommittees/Impact
Credit Suisse AGSenior Advisor2009–May 2014Advised global M&A; preceded by Chair & Head of EMEA M&A, leading franchise in complex cross‑border transactions
Credit Suisse AGChairman & Head of EMEA M&AUntil 2009Led regional M&A; built domain expertise in finance, governance and board advisory
The First Boston CorporationSenior positionsNot disclosedInvestment banking leadership roles (career foundation)
Bankers TrustSenior positionsNot disclosedInvestment banking leadership roles (career foundation)
Barclays de Zoete WeddSenior positionsNot disclosedInvestment banking leadership roles (career foundation)
Shire plcChair2011–2019Board leadership through strategic phases; governance oversight
BHP Group plc and BHP LimitedNon‑Executive Director2019–2021Oversight in global resources, risk governance

External Roles

OrganizationRoleStatusNotes/Committees/Impact
Diageo plcSenior Independent DirectorCurrentSenior independent oversight; governance and shareholder engagement role
Unilever plcNon‑Executive DirectorCurrentOversight in global consumer products
COFRA Holding plcNon‑Executive DirectorCurrentPrivate holding company; oversight role
UK Takeover PanelMemberCurrentRegulates UK takeovers; ensures fair shareholder treatment

Board Governance

  • Independent Non‑Executive Chair leadership structure; responsibilities include presiding over Board meetings, agenda setting with CEO, liaison between management and non‑management directors, leading Board/CEO performance assessments, and facilitating executive sessions of independent directors; in 2024 these sessions were led by Ms. Kilsby.
  • Independence affirmed under NYSE rules; Board is 89% independent; Kilsby determined independent. Retirement‑age policy at 72 supports refreshment.
  • Meeting attendance: each director nominee and continuing director attended >90% of Board/committee meetings in 2024; all then‑serving directors attended the 2024 Annual Meeting (except two retirees).
CommitteeRole2024 Meetings
NESGChair4
ExecutiveChair0
Board (overall)Non‑Executive Chair (leads exec sessions)5
Audit (context)Not a member8
Compensation (context)Not a member5

Fixed Compensation

  • Non‑employee director program (2024): Cash retainer $120,000; Equity retainer $160,000 in Company stock; Committee chair fee $15,000 (Audit/Comp/NESG); Board Chair fee $200,000; stock ownership guideline = 5× cash retainer ($600,000) within five years; all directors meet or are within the allowed period.
  • Anti‑hedging/anti‑pledging policy prohibits hedging or pledging of Company stock.
YearCash Fees ($)Board/NESG Chair Fees IncludedEquity Retainer (Grant‑Date Fair Value, $)All Other Comp ($)Total ($)
2023327,500 Board Chair + NESG Chair 159,994 6,451 493,945
2024335,000 Board Chair + NESG Chair 159,986 16,019 (incl. incremental Co. aircraft cost) 511,005

Director benefits include group life/AD&D and business travel accident insurance, concierge health service, cybersecurity privacy protection, and broad‑based programs (charitable matching, product purchase). Personal aircraft use is generally not permitted (other than CEO), but may be waived in limited emergency circumstances; the 2024 “All Other Compensation” for Ms. Kilsby includes incremental aircraft cost.

Performance Compensation

YearEquity Grant DateShares GrantedGrant Price ($)Grant Value ($)
2023May 2023 2,474 64.67 160,000 (rounded)
2024May 2024 2,197 72.82 160,000 (rounded)

Notes: Directors may elect to convert cash fees to stock and/or defer equity under the Non‑Employee Director Deferred Compensation Plan; deferral examples are disclosed for other directors (Finan/Hackett/etc.). No options/PSUs are granted to directors; director equity is time‑based Company stock intended to align interests.

Other Directorships & Interlocks

CompanySectorRolePotential Interlock/Conflict Notes
Diageo plcBeveragesSenior Independent DirectorNo related‑party transactions disclosed by FBIN since 12/31/2023.
Unilever plcConsumer ProductsNon‑Executive DirectorNo related‑party transactions disclosed by FBIN since 12/31/2023.
COFRA Holding plcPrivate (Holding Company)Non‑Executive DirectorNo related‑party transactions disclosed by FBIN since 12/31/2023.

Policy limits: FBIN directors restricted from serving on >3 public company boards in addition to FBIN; Audit Committee members limited to ≤2 other audit committees; new public board roles require approval from NESG Chair (Kilsby). Annual review of outside commitments by NESG Committee.

Expertise & Qualifications

  • Distinguished career in global investment banking; expertise in M&A, finance, and international business; prior senior roles at Credit Suisse, First Boston, Bankers Trust, and BZW.
  • Extensive board leadership experience including Chair of Shire plc (2011–2019) and prior BHP boards; currently Senior Independent Director at Diageo and director at Unilever.
  • UK Takeover Panel member, adding regulatory rigor to governance perspective.

Equity Ownership

HolderShares Beneficially Owned% of ClassGuideline Compliance
Susan S. Kilsby20,261 <1% Directors meet or are within 5‑yr window to meet 5× cash retainer stock guideline

Anti‑hedging/anti‑pledging policy applies to directors; no pledging allowed.

Governance Assessment

  • Board effectiveness: As independent Non‑Executive Chair and NESG Chair, Kilsby leads board/committee evaluations and independent executive sessions, interviews directors/management as part of annual assessments—clear engagement and oversight signal.
  • Independence and attendance: Independence affirmed by Board; >90% meeting attendance in 2024; attended the 2024 Annual Meeting—positive engagement and reliability indicators.
  • Compensation alignment: Director pay calibrated to market with mix of cash retainer, Board/NESG chair fees, and time‑based stock; robust stock ownership guidelines (5× cash retainer) and anti‑hedging/pledging policy strengthen alignment.
  • RED FLAG (limited): 2024 “All Other Compensation” includes incremental cost for personal use of Company aircraft for Ms. Kilsby, despite general prohibition (except CEO) with emergency waiver; not a recurring pattern disclosed, but noteworthy for optics.
  • Conflicts/related parties: Company reports no related‑party transactions requiring disclosure since 12/31/2023; formal Conflicts of Interest process and NESG oversight reduce risk.

Overall, Kilsby’s role as independent Chair and NESG Chair, combined with high attendance and strong governance processes, supports investor confidence; the isolated aircraft perquisite cost merits monitoring but is framed within policy and exceptions.